Myocardial matrix metalloproteinase activity and abundance with congestive heart failure

被引:110
|
作者
Coker, ML
Thomas, CV
Clair, MJ
Hendrick, JW
Krombach, RS
Galis, Z
Spinale, FG
机构
[1] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
关键词
extracellular matrix; left ventricle;
D O I
10.1152/ajpheart.1998.274.5.H1516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The left ventricular (LV) myocardial collagen matrix has been proposed to participate in the maintenance of LV geometry. Thus alterations in the composition of the LV myocardial collagen matrix may influence LV function. The matrix metalloproteinases (MMPs) are a family of enzymes that contribute to extracellular remodeling in several disease states. However, the types of MMPs expressed in the normal and congestive heart failure (CHF) state and the relation to MMP activity remained unclear. Accordingly after 3 wk of pacing (240 beats/min), changes in LV function, substrate-specific MMP activity, and MMP subclass abundance were measured in comparison with control pigs (n = 6). Changes in LV function and geometry were measured by echocardiography; LV end-diastolic dimension increased (3.6 +/- 0.1 vs. 6.0 +/- 0.1 cm, P < 0.05) and LV fractional shortening decreased (47 +/- 1 vs. 15 +/- 1%, P < 0.05) compared with controls. Degradation of fibrillar collagen is achieved through the combined action of interstitial collagenase (MMP-1), gelatinase A (MMP-2), and stromelysin (MMP-3) (He, C., S. Wilheilm, A. Pentland, B. Marmer, G. Grant, A. Eisen, and G. Goldberg. Proc. Natl. Acad. Sci. USA 86: 2632-2636, 1989; Woessner, J. FASEB J. 5: 2145-2154, 1991). Accordingly, the relative abundance of specific MMPs (MMP-1, MMP-2, and MMP-3) was examined by immunoblotting. With pacing CHF, the relative abundance for MMP-1 increased to 319 +/- 94%, MMP-2 increased to 194 +/- 31%, and MMP-3 increased to 493 +/- 159% (all P < 0.05). With pacing CHF, LV myocardial zymographic activity for the substrate gelatin increased by 119% (P < 0.05) and for the substrate collagen III by 153% (P < 0.05) over controls. Caseinolytic activity also increased with pacing CHF by 139% (P < 0.05) over controls. In conclusion, LV myocardial MMP activity and abundance increased with pacing-induced CHF. These findings demonstrate that pacing-induced CHF leads to changes in myocardial MMP activity and expression that may be responsible for LV remodeling in CHF.
引用
收藏
页码:H1516 / H1523
页数:8
相关论文
共 50 条
  • [1] Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure
    Thorud, HMS
    Stranda, A
    Birkeland, JA
    Lunde, PK
    Sjaastad, I
    Kolset, SO
    Sejersted, OM
    Iversen, PO
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (02) : R389 - R394
  • [2] Matrix metalloproteinase 2 is expressed in the heart of patients with congestive heart failure
    Burger, P
    Bernheim, A
    Linka, A
    Kiowski, W
    Rickli, H
    Brunner-La Rocca, HP
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 77 - 77
  • [3] Selective matrix metalloproteinase inhibition influences LV geometry and myocardial structure in developing congestive heart failure
    O'Neill, TP
    King, MK
    Coker, ML
    Goldberg, AT
    Morrison, AE
    Holder, JR
    Gunasinghe, HR
    Mukherjee, R
    Wendt, KA
    Zile, MR
    Spinale, FG
    [J]. CIRCULATION, 2000, 102 (18) : 292 - 292
  • [4] Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure
    Song, Yao-Hong
    Cai, Hui
    Gu, Ning
    Qian, Chun-Fa
    Cao, Shou-Pei
    Zhao, Zhi-Ming
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (04) : 541 - 549
  • [5] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [6] CYTOKINE AND MATRIX METALLOPROTEINASE EXPRESSION IN BLOOD SAMPLES OF DOGS WITH CONGESTIVE HEART FAILURE
    Fonfara, Sonja
    Tew, Simon
    Clegg, Peter
    Dukes-McEwan, Joanna
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (03) : 671 - 671
  • [7] Induction of myocardial extracellular matrix metalloproteinase inducer protein in end-stage human heart failure: Relation to matrix metalloproteinase activity
    Gunasinghe, SK
    Coker, ML
    Heung, LJ
    Goldberg, AT
    Joffs, C
    Zellner, JL
    Crumbley, AJ
    Spinale, FG
    [J]. CIRCULATION, 2000, 102 (18) : 292 - 292
  • [8] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure - Reply
    Fonarow, Gregg C.
    Horwich, Tamara B.
    Eshaghian, Shervin
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [9] Matrix metalloproteinase gene polymorphisms in heart failure: new pieces to the myocardial matrix puzzle
    Spinale, FG
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (08) : 631 - 633
  • [10] Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure
    Ichihara, S
    Noda, A
    Nagata, K
    Obata, K
    Xu, JL
    Ichihara, G
    Oikawa, S
    Kawanishi, S
    Yamada, Y
    Yokota, M
    [J]. CARDIOVASCULAR RESEARCH, 2006, 69 (03) : 726 - 735